Back to Rankings

ESLA

Estrella ImmunopharmaF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ESLA vs peer average
44/100
ESLA vs. peer average (F vs. F)
Grade spread
B 1 · F 7
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

LITS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $35.05M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerLITSLite Strategy
ESLA
Estrella Immunopharma
LITS
Lite Strategy
Grade
F
F
Momentum
28
20
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs LITS

ESLA / LITS
Grade Position
Below peers
ESLA vs. peer average (F vs. F)
44/100
Momentum
28
ESLA
Value
41
ESLA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ESLA
1
LITS
Lite Strategy Inc Common
F
20/100
Even
2
VYNE
VYNE Therapeutics Inc Common
F
20/100
Even
3
VERU
Veru Inc Common
F
20/100
Even
4
GNTA
Genenta Science SpA ADR
F
20/100
Even
5
NTRB
Nutriband Inc Common
B
80/100
-3
LITS is the first peer returned for this comparison set.